Aardvark Therapeutics, Inc. (AARD) Tops Q2 EPS by 4c

Aardvark Therapeutics, Inc. (NASDAQ: AARD) reported Q2 EPS of ($0.66), $0.04 better than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Aardvark Therapeutics, Inc. (AARD) click here.

You May Also Be Interested In

• Paramount Weighs Tapping Musk For Equity Investment - Semafor
• Scotiabank Reiterates Sector Outperform Rating on Hemlo Mining (HMMC:CN)
• Stitch Fix (SFIX) call put ratio 4.9 calls to 1 put with a focus on October 2.5 and 5 calls into quarter results